Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
11:22:44 2026-10-27 am EDT
|
5-day change | 1st Jan Change | ||
| 0.0490 USD | -0.33% |
|
-1.80% | -12.34% |
| Market Cap | 20.68M 18.49M 17.11M 15.49M 28.99M 1.97B 29.46M 206M 81.43M 1.03B 77.61M 75.95M 3.26B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 23.41M 20.93M 19.36M 17.53M 32.81M 2.23B 33.35M 233M 92.17M 1.16B 87.84M 85.97M 3.69B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -0.33% | ||
| 1 week | -1.80% | ||
| Current month | -14.19% | ||
| 1 month | -14.34% | ||
| 3 months | -18.33% | ||
| 6 months | -4.85% | ||
| Current year | -12.34% |
| 1 week | 0.05 |  | 0.05 |
| 1 month | 0.05 | | 0.06 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.08 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 2024-04-15 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 2012-05-14 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 2019-03-24 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 2017-04-02 | |
John Lacey
BRD | Director/Board Member | 78 | 2018-04-26 |
Edward Pershing
CHM | Chairman | 73 | 2018-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/10/26 | Exercice | Chief Executive Officer | -22,609 | 0.0054% | ||
| 10/3/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 9/18/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.33% | -1.80% | -30.77% | -29.80% | 20.68M | |
| -3.10% | -3.43% | +36.29% | +67.69% | 65.28B | |
| +0.28% | +0.21% | +10.02% | +77.84% | 54.57B | |
| -0.09% | +1.50% | +9.64% | +101.65% | 53.59B | |
| +0.93% | +2.78% | +26.62% | +53.00% | 45.03B | |
| -2.00% | -5.74% | +14.90% | +112.64% | 42.17B | |
| +0.92% | -5.76% | +219.40% | +895.27% | 39.42B | |
| -0.74% | -4.84% | +14.53% | +44.45% | 32.71B | |
| -2.70% | -7.34% | +23.17% | +0.36% | 24.01B | |
| +1.08% | +15.37% | +60.53% | +49.58% | 26.5B | |
| Average | -0.57% | +1.84% | +38.43% | +137.27% | 38.33B | |
| Weighted average by Cap. | -0.68% | +1.72% | +43.16% | +154.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.55 0.51 0.46 0.87 58.72 0.88 6.14 2.43 30.71 2.32 2.27 97.24 | 0.34 0.3 0.28 0.25 0.47 31.98 0.48 3.35 1.32 16.73 1.26 1.23 52.96 |
| Net income | -4.76M -4.26M -3.94M -3.57M -6.68M -453M -6.79M -47.41M -18.75M -237M -17.87M -17.49M -750M | -5.43M -4.86M -4.49M -4.07M -7.61M -517M -7.74M -54.07M -21.39M -270M -20.38M -19.95M -856M |
| Net Debt | 2.88M 2.57M 2.38M 2.16M 4.03M 274M 4.1M 28.64M 11.33M 143M 10.8M 10.57M 453M | 2.73M 2.44M 2.26M 2.04M 3.82M 259M 3.89M 27.15M 10.74M 136M 10.24M 10.02M 430M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | $0.0490 | -0.33% | 30,200 |
| 26-10-26 | $0.0492 | +1.65% | 189,050 |
| 26-10-23 | $0.0484 | -3.01% | 26,823 |
| 26-10-22 | $0.0499 | 0.00% | 5,211 |
| 26-10-21 | $0.0499 | 0.00% | 20,100 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
